- decreased circulating HDL cholesterol level / IMPC
- abnormal tibia morphology / IMPC
- increased circulating chloride level / IMPC
- increased lean body mass / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating creatinine level / IMPC
- decreased circulating glucose level / IMPC
- increased blood urea nitrogen level / IMPC
- increased circulating sodium level / IMPC
- increased circulating amylase level / IMPC
- decreased mean platelet volume / IMPC
- decreased total body fat amount / IMPC
- increased bone mineral content / IMPC
- decreased fasting circulating glucose level / IMPC
C57BL/6N-Atm1Brd Cbx6tm1a(EUCOMM)Wtsi/WtsiCnbc
Status | Available to order |
EMMA ID | EM:06102 |
International strain name | C57BL/6N-Atm1Brd Cbx6tm1a(EUCOMM)Wtsi/WtsiCnbc |
Alternative name | EPD0445_7_A03 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Cbx6tm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Cbx6 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0445_7_A03. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- increased circulating chloride level / IMPC
- increased bone mineral content / IMPC
- abnormal tibia morphology / IMPC
- increased circulating sodium level / IMPC
- decreased fasting circulating glucose level / IMPC
- increased circulating amylase level / IMPC
- increased lean body mass / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased circulating creatinine level / IMPC
- increased blood urea nitrogen level / IMPC
- decreased mean platelet volume / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating glucose level / IMPC
- decreased total body fat amount / IMPC
MGI phenotypes (allele matching)
- decreased body weight / MGI
- abnormal bile duct morphology / MGI
- abnormal Mullerian duct morphology / MGI
- abnormal liver vasculature morphology / MGI
- perimembraneous ventricular septal defect / MGI
- absent hypoglossal nerve / MGI
- abnormal Mullerian duct topology / MGI
- abnormal infrahyoid muscle connection / MGI
- blood in lymph vessels / MGI
- abnormal vitelline vein topology / MGI
- abnormal vertebral artery topology / MGI
- heterochrony / MGI
MGI phenotypes (gene matching)
- decreased body weight / MGI
- no abnormal phenotype detected / MGI
- abnormal bile duct morphology / MGI
- abnormal Mullerian duct morphology / MGI
- abnormal liver vasculature morphology / MGI
- perimembraneous ventricular septal defect / MGI
- absent hypoglossal nerve / MGI
- abnormal Mullerian duct topology / MGI
- abnormal infrahyoid muscle connection / MGI
- blood in lymph vessels / MGI
- abnormal vitelline vein topology / MGI
- abnormal vertebral artery topology / MGI
- heterochrony / MGI
- hemangioma / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).